| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5687741 | The Journal of Urology | 2016 | 19 Pages |
Abstract
Once daily T-sol administered for 6 months in an open label study did not indicate new safety concerns, and the outcomes of low sex drive and low energy showed further improvement after the double-blind phase.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Gerald Brock, Darell Heiselman, Jack Knorr, Xiao Ni, Kraig Kinchen,